← Back to all substances
J
vancomycin
259ms
Level 1
✓ What this shows
- • Reported adverse events from FDA FAERS
- • Descriptive statistics from a locked corpus
- • Data verified with cryptographic hashes
✗ What this is NOT
- • Not medical advice or recommendations
- • Not proof of causality
- • Not a complete safety profile
About this substance
INDICATIONS AND USAGE Vancomycin Hydrochloride for Injection, USP is indicated for the treatment of serious or severe infections caused by susceptible strains of methicillin-resistant (β-lactam-resistant) staphylococci. It is indicated for penicillin-allergic patients, for patients who cannot receiv...
Known as: Vancomycin Hydrochloride
Route: INTRAVENOUS
Source: OpenFDA Drug Labels · Reference only · Not medical advice
500
Events in Corpus
v20260131-01
70,246
Total in FDA
93%
Serious Reports
144
Fatal Outcomes
Seriousness
Serious
466
Non-Serious
34
Sex Distribution
Male
234
Female
210
Unknown
56
Age Distribution
0-17
45
18-40
61
41-64
171
65-84
141
85+
13
Unknown
69
Outcomes
Recovered/Resolved
354
Recovering/Resolving
122
Not Recovered/Not Resolved
200
Recovered with Sequelae
8
Fatal
144
Unknown
1257
Top Reported Reactions (click to view reports)
Verification Data
Corpus Version: v20260131-01
Root Hash: ec5727564d1ed19be5b08b26d3866f446b12d3d388f5a8cd713332c6d97ad264
Stats Hash: N/A
EVE Decision ID: EVE-MED-20260402-c904e9
This output reports adverse events from FDA FAERS. It does not constitute medical advice.
Molecular Structure (reference)
Structural visualization for identification only.
This visualization shows the molecular structure for identification purposes only. It does not represent pharmacological effect, safety, or clinical relevance.
Loading structure...